Adjuvant Therapy of Breast Cancer V

Name: Adjuvant Therapy of Breast Cancer V
Brand: Springer Nature
SKU: 9783642792786
Availability: InStock

Best Price (Coupon Required):
Buy Adjuvant Therapy of Breast Cancer V for $76.50 at @ Link.springer.com when you apply the 10% OFF coupon at checkout.
Click “Get Coupon & Buy” to copy the code and unlock the deal.

Set a price drop alert to never miss an offer.

1 Offer Price Range: $84.99 - $84.99

BEST PRICE

Single Product Purchase

$76.50

@ Link.springer.com with extra coupon

Price Comparison

Seller	Contact Seller	List Price	On Sale	Shipping	Best Promo	Final Price	Volume Discount	Financing	Availability	Seller's Page
BEST PRICE 1 Product Purchase @ Link.springer.com		$84.99	$84.99		10% OFF This deals requires coupon	$76.50		See Site	In stock	Visit Store

Product Details

Brand

Springer Nature

Manufacturer

N/A

Part Number

GTIN

9783642792786

Condition

New

Product Description

We often hear physicians, health care professionals, poli ticians, and patient advocates that "nothing has happened in the treatment of breast cancer," since patients with breast cancer, the most frequent neoplastic condition in women in industrialized countries, are continuing to suffer relapse and succumb to this dreadful disease! This negativistic attitude does not seem to be justified, but, why is the transmission of clinical trial results into general practice, and with it progress, such a slow process? After many decades of frustrating stagnation of long-term survival expectations, in all stages of early, oper/lble breast cancer treated only by surgery and locoregional radio therapy, adjuvant systemic therapy (chemo- as well as endocrine treatments) clearly showed to significantly benefit in terms of disease-free and overall survival. This evolution has been extensively expounded on by the Worldwide Oxford Overview and the Expert Consensus Panel at the fourth International Conference 'on Adjuvant Therapy of Primary Breast Cancer in St. Gallen (Early Breast Cancer Trialists' Collaborative Group 1992; Glick et al. 1992). What has happened since then? During the past 3-5 years, several new concepts and treatment strategies have emerged and have been studied in various major breast cancer groups and treatment centers worldwide. Some of these can already be considered to assist in the primary treatment of operable breast cancer today, while others are . still undergoing clini,cal trials for better definition of their practical usefulness.

Available Colors

N/A

Available Sizes

N/A

Reviews

0 reviews

5 stars

4 stars

3 stars

2 stars

1 star

Questions & Answers

Similar Products

Controlling & Management Review Sonderheft 3-2014

$59.99

Virtue Ethics for Women 1250-1500

$109.99

Management von Transaktionsbanken

$39.99

Aufgaben und Lsungen aus der Gleich- und Wechselstromtechnik

$84.99

Analytic Methods for Design Practice

$109.99

Disaster Management and Information Technology

$139.99

The Invention of Europe in French Literature and Film

$39.99

Angewandte Politikforschung

$84.99

Wie das Leben zum Urlaub wird

$24.99

New and Evolving Infections of the 21st Century

$219.99

Economic History of Europe: Twentieth Century

$74.99

Photonic Crystal Fibers

$109.99

Digital Removable Partial Denture Technology

$149.00

Analytical Chemistry Associated with the Destruction of Chemical Weapons

$169.00

Mammalian Cell Viability

$84.99

Telekommunikation mit dem PC

$84.99

The Mast Cell

$109.99

Nonlinear Analysis

$109.99

Modeling, Computing and Data Handling Methodologies for Maritime Transportation

$199.99

Many Lives, Many Masters- The True Story of a Prominent Psychiatrist, His Young Patient, and the Past-Life Therapy That Changed Both Their Lives by Br

$22.00